Bcl6, Irf2, and Notch2 promote nonclassical monocyte development

S. Epelman, K. J. Lavine, G. J. Randolph, Origin and functions of tissue macrophages. Immunity 4121–35 (2014).

P. B. Narasimhan, P. Marcovecchio, A. A. J. Hamers, C. C. Hedrick, Nonclassical monocytes in health and disease. Year. Rev. Immunol. 37439–456 (2019).

M. Zembala, W. Uracz, I. Ruggiero, B. Mytar, J. Pryjma, Isolation and functional characteristics of FcR+ and FcR- human monocyte subsets J. Immunol. 1331293–1299 (1984).

B. Passlick, D. Flieger, H. W. Ziegler-Heitbrock, Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 742527–2534 (1989).

H. W. Ziegler-Heitbrock et al., The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur. J. Immunol. 232053–2058 (1993).

G. Fingerle et al., The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 823170–3176 (1993).

W. A. Nockher, L. Bergmann, J. E. Scherberich, Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin. Exp. Immunol. 98369–374 (1994).

W. A. Nockher, J. E. Scherberich, Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis Infect. Immun. 662782–2790 (1998).

A. Rivier et al., Blood monocytes of untreated asthmatics exhibit some features of tissue macrophages. Clin. Exp. Immunol. 100314–318 (1995).

N. Thieblemont, L. Weiss, H. M. Sadeghi, C. Estcourt, N. Haeffner-Cavaillon, CD14lowCD16high: A cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur. J. Immunol. 253418–3424 (1995).

S. Jung et al., Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 204106–4114 (2000).

F. Geissmann, S. Jung, D. R. Littman, Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 1971–82 (2003).

C. Sunderkötter et al., Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 1724410–4417 (2004).

M. A. Ingersoll et al., Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 115e10–9 (2010).

C. Auffray et al., Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317666–670 (2007).

L. M. Carlin et al., Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. Cell 153362–375 (2013).

R. N. Hanna et al., Patrolling monocytes control tumor metastasis to the lung. Science 350985–990 (2015).

P. B. Narasimhan et al., Patrolling monocytes control NK cell expression of activating and stimulatory receptors to curtail lung metastases. J. Immunol. 204192–198 (2020).

G. D. Thomas et al., Deleting an Nr4a1 super-enhancer subdomain ablates Ly6C(low) monocytes while preserving macrophage gene function. Immunity 45975–987 (2016).

D. K. Fogg et al., A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 31183–87 (2006).

C. Varol et al., Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J. Exp. Med. 204171–180 (2007).

J. Hettinger et al., Origin of monocytes and macrophages in a committed progenitor. Nat. Immunol. 14821–830 (2013).

S. Kawamura et al., Identification of a human clonogenic progenitor with strict monocyte differentiation potential: A counterpart of mouse cMoPs. Immunity 46835–848.e4 (2017).

J. K. Alder et al., Kruppel-like factor 4 is essential for inflammatory monocyte differentiation in vivo. J. Immunol. 1805645–5652 (2008).

M. W. Feinberg et al., The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J. 264138–4148 (2007).

D. Kurotaki et al., Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation. Blood 1211839–1849 (2013).

E. W. Scott, M. C. Simon, J. Anastasi, H. Singh, Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 2651573–1577 (1994).

S. Yona et al., Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 3879–91 (2013).

A. Mildner et al., Genomic characterization of murine monocytes reveals C/EBPβ transcription factor dependence of Ly6C- cells. Immunity 46849–862.e7 (2017).

R. N. Hanna et al., The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes. Nat. Immunol. 12778–785 (2011).

R. N. Hanna et al., NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. circ. Beef. 110416–427 (2012).

X. Liu et al., Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction. Nature 567525–529 (2019).

A. Tamura et al., C/EBPbeta is required for survival of Ly6C(-) monocytes. Blood 1301809–1818 (2017).

A. Tamura et al., Accelerated apoptosis of peripheral blood monocytes in Cebpb-deficient mice. Biochem. Biophys. Res. Commun. 464654–658 (2015).

J. Gamrekelashvili et al., Regulation of monocyte cell fate by blood vessels mediated by notch signalling. Nat. Common. 712597 (2016).

T. Nakano, H. Kodama, T. Honjo, Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 2651098–1101 (1994).

T. M. Schmitt, J. C. Zúñiga-Pflücker, Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17749–756 (2002).

M. E. Kirkling et al., Notch signaling facilitates in vitro generation of cross-presenting classical dendritic cells. Cell Rep. 233658–3672.e6 (2018).

Y. Sasai, R. Kageyama, Y. Tagawa, R. Shigemoto, S. Nakanishi, Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. Genes Dev. 62620–2634 (1992).

S. Jarriault et al., Signalling downstream of activated mammalian Notch. Nature 377355–358 (1995).

P. Bagadia et al., Bcl6-independent in vivo development of functional type 1 classical dendritic cells supporting tumor rejection. J. Immunol. 207125–132 (2021).

I. Kwok et al., Combinatorial single-cell analyses of granulocyte-monocyte progenitor heterogeneity reveals an early uni-potent neutrophil progenitor. Immunity 53303–318.e5 (2020).

MMH you al., Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion. J. Exp. Med. 2132931–2947 (2016).

T. Matsuyama et al., Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 7583–97 (1993).

S. Hida et al., CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Immunity 13643–655 (2000).

T. Mizutani et al., Homeostatic erythropoiesis by the transcription factor IRF2 through attenuation of type I interferon signaling. Exp. Hematol. 36255–264 (2008).

B. Morgan et al., Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 162004–2013 (1997).

J. H. Wang et al., Aiolos regulates B cell activation and maturation to effector state. Immunity 9543–553 (1998).

F. J. Quintana et al., Aiolos promotes TH17 differentiation by directly silencing Il2 expression. Nat. Immunol. 13770–777 (2012).

L. Pasqualucci et al., Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 1012914–2923 (2003).

X. Wang, Z. Li, A. Naganuma, B. H. Ye, Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas. Proc. Natl. Acad. Sci. U.S.A. 9915018–15023 (2002).

U. Cytlak et al., Ikaros family zinc finger 1 regulates dendritic cell development and function in humans. Nat. Common. 91239 (2018).

D. Korenfeld et al., STAT3 gain-of-function mutations underlie deficiency in human nonclassical CD16(+) monocytes and CD141(+) dendritic cells. J. Immunol. 2072423–2432 (2021).

A. E. Moran et al., T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J. Exp. Med. 2081279–1289 (2011).

S. L. Lee et al., Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science 269532–535 (1995).

A. L. Dent, A. L. Shaffer, X. Yu, D. Allman, L. M. Staudt, Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276589–592 (1997).

R. J. Johnston et al., Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 3251006–1010 (2009).

[ PubMed ]Taki S., Nakajima S., Ichikawa E., Saito T., Hida S. IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells. J. Immunol. 1746005–6012 (2005).

T. Sato et al., Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Night. With. 15696–700 (2009).

S. Hida, M. Tadachi, T. Saito, S. Taki, Negative control of basophil expansion by IRF-2 critical for the regulation of Th1/Th2 balance. Blood 1062011–2017 (2005).

D. Sakano et al., BCL6 canalizes notch-dependent transcription, excluding mastermind-like1 from selected target genes during left-right patterning. Dev. Cell 18450–462 (2010).

L. Tiberi et al., BCL6 controls neurogenesis through Sirt1-dependent epigenetic repression of selective notch targets. Nat. Neurosci. 151627–1635 (2012).

S. Lukhele et al., The transcription factor IRF2 drives interferon-mediated CD8+ T cell exhaustion to restrict anti-tumor immunity. Immunity 552369–2385.e10 (2022).

S. Morita, T. Kojima, T. Kitamura, Plat-E: An efficient and stable system for transient packaging of retroviruses. Gene Ther. 71063–1066 (2000).